readthroughSign in
CompanyIBIONasdaqNew York, NY

iBio, Inc.

iBio is a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic, cardiopulmonary, and oncologic diseases using antibody engineering and AI-driven discovery.

8-KNov 16Latest SEC filing
Nov 16Latest story